Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of NovoMix 30 vs Mixtard 30/70 in Type 2 Diabetes
NCT01697618Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Apr 1997
- Primary completion
- Nov 1998
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of biphasic insulin aspart in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Novo Nordisk. Primary endpoint: Area under the serum insulin curve. Started Apr 1997; status: completed.
02
Drugs
biphasic insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01697618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01697618.